Although the parasite
responsible for causing malaria has been in existence for at least 50,000 to
100,000 years, its population significantly increased around 10,000 years ago,
a time concurrent with the beginnings of agriculture and human settlements.
Malaria was once common in most of Europe and North America and was only
declared eliminated from the United States in 1951. The World Health
Organization estimated that in 2010 there were 219 million cases of malaria and
600,000 deaths, 90 percent of them in Africa.
The lifecycle of the malaria
parasite, which involves both an insect and a human vector, was determined
during the final decades of the nineteenth century. In 1880, the French army
doctor Charles-Louis-Alphonse Laveran observed the presence of protozoa
(single-celled microbes) within the red blood cells of malaria-infected
patients and speculated that it might be responsible for its cause. Working in
Calcutta, in 1898, the British physician Ronald Ross determined the complete
lifecycle of the malaria parasite in mosquitoes and established that the
mosquito was the vector carrying the Plasmodium parasite to humans. Ross and
Laveran were awarded the 1902 and 1907 Nobel Prizes, respectively.
The female Anopheles
mosquito, carrying the Plasmodium, feeds on human blood. In the process, it
injects the parasite into the bloodstream, through which it invades liver cells
and produces tens of thousands of merozoites per liver cell. The merozoites
enter the bloodstream (where they cause malaria-characteristic periodic chills
and fever), penetrate red blood cells, and reproduce. When a mosquito bites an
infected human, it ingests sporocytes, which travel from the mosquito’s gut to
its salivary gland, restarting the cycle when it bites another victim.
One type of genetic
resistance to malaria has been attributed to changes in red blood cells,
deforming the cells into a sickle shape, which interferes with the parasite’s
ability to invade and reproduce in these cells. Sickle-cell disease, the most
commonly inherited disease among individuals of African descent, reduces the
frequency and severity of malaria attacks, particularly in young children who
are most affected by malaria. Sickle-cell disease may, therefore, confer an
evolutionary advantage for those residing in Africa where malaria is prevalent.
No comments:
Post a Comment